|
Roldán V, Vílchez JA, Manzano-Fernández S, Jover E, Gálvez J, Puche CM, Valdés M, Vicente V, Lip GY, Marín F. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Stroke. 2014 Mar;45(3):696-701. doi: 10.1161/STROKEAHA.113.003338. PubMed PMID: 24519407.
AÑO: 2014; IF: 5.761
|
|
Sánchez-Martínez M., López-Cuenca Á., Marín F., Manzano-Fernández S. Red cell distribution width and coronary artery disease. Response. Revista Espanola de Cardiologia. 1 November 2014. 67:968-969. 10.1016/j.recesp.2014.07.004
AÑO: 2014; IF: 3.792
|
|
Marín F., Huber K., Lip G.Y.H. Antithrombotic therapy in atrial fibrillation and stent implantation: Treatment or threats by the use of triple or dual antithrombotic therapy. Thrombosis and Haemostasis. 2013. 110:623-625. 10.1160/TH13-08-0677
AÑO: 2013; IF: 5.76
|
|
Ruiz-Nodar J.M., Marín F., Lip G.Y.H. Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention. Revista Espanola de Cardiologia. January 2013. 66:12-16. 10.1016/j.recesp.2012.07.018
AÑO: 2013; IF: 3.342
|
|
Orenes-Piñero E, Hernández-Romero D, de Torre C, Vilchez JA, Martínez M, Romero-Aniorte AI, Climent V, García-Honrubia A, Valdés M, Marín F. Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches. Ann Med. 2013 Jun;45(4):341-7. doi: 10.3109/07853890.2013.792555. PubMed PMID: 23701180.
AÑO: 2013; IF: 4.733
|